Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF – Get Rating) was the target of a significant growth in short interest during the month of December. As of December 15th, there was short interest totalling 1,900 shares, a growth of 18.8% from the November 30th total of 1,600 shares. Based on an average trading volume of 3,700 shares, the short-interest ratio is currently 0.5 days.
Algernon Pharmaceuticals Trading Down 3.2 %
Shares of AGNPF stock opened at $1.63 on Friday. The business's 50 day simple moving average is $1.98 and its 200 day simple moving average is $2.77. Algernon Pharmaceuticals has a one year low of $1.52 and a one year high of $9.28.
Get Algernon Pharmaceuticals alerts:About Algernon Pharmaceuticals
(Get Rating)
Algernon Pharmaceuticals Inc operates as a clinical stage pharmaceutical development company. It focuses on the areas of non-alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, and acute lung injury associated with COVID-19 in Canada and Australia.Read More
- Get a free copy of the StockNews.com research report on Algernon Pharmaceuticals (AGNPF)
- MarketBeat: Week in Review 12/26 – 12/30
- The Dogs Of Tech: It's Time For A Bite Of These Stocks
- Does This Acquisition Make Microsoft a Bear Market Buy?
- Should You Warm up to Generac Stock for the Winter?
- Is Kintara Therapeutics A Hidden Gem?
Receive News & Ratings for Algernon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Algernon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.